David Illingworth, CEO of Smith & Nephew, has said that he expects the orthopedic device market slowdown to continue for several months as individuals defer procedures as a result of the economic downturn, according to a report in the Wall Street Journal.
The $11 billion hip and knee replacement device market has slowed this year. Analysts expect growth in the market to be “a couple percentage points below the typical high single-digit pace of market expansion,” according to the report.
Read the Wall Street Journal’s report on the orthopedic device market slowdown.
The highest-paid CEOs at spine and orthopedic medtech companies saw total compensation of more than $20 million. Here is how…
Elon Musk’s brain-implant company, Neuralink, may soon have a new competitor in the market. Neurotechnology startup Precision Neuroscience has earned…
Alphatec CEO Patrick Miles earned about $6.2 million in total compensation, according to the company’s April 11 Securities and Exchange…
Comments are closed.